References
- Allen AL, Siegfried EC. What's new in human papillomavirus infection. Curr Opin Pediatr. 2000;12(4):365–369.
- Frazer IH. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 2009;384(2):410–414.
- Ockenfels HM. Therapeutic management of cutaneous and genital warts. J Dtsch Dermatol Ges. 2016;14(9):892–899.
- Sterling JC, Gibbs S, Haque Hussain SS, et al. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696–712.
- Wessels I, Maywald M, Rink L. Zinc as a Gatekeeper of Immune Function. Nutrients. 2017;9(12):1286.
- Read SA, Parnell G, Booth D, et al. The antiviral role of zinc and metallothioneins in hepatitis C infection. J Viral Hepat. 2018;25(5):491–501.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
- Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
- Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. 2002;146(3):423–431.
- Lopez-Garcia DR, Gomez-Flores M, Arce-Mendoza AY, et al. Oral zinc sulfate for unresponsive cutaneous viral warts: too good to be true? A double-blind, randomized, placebo-controlled trial. Clin Exp Dermatol. 2009;34(8):e984–e985.
- Mun JH, Kim SH, Jung DS, et al. Oral zinc sulfate treatment for viral warts: an open-label study. J Dermatol. 2011;38(6):541–545.
- Sadighha A. Oral zinc sulphate in recalcitrant multiple viral warts: a pilot study. J Eur Acad Dermatol Venereol. 2009;23(6):715–716.
- Stefani M, Fontenelle E, Bottino G, et al. [Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts]. An Bras Dermatol. 2009;84(1):23–29.
- Yaghoobi R, Sadighha A, Baktash D. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol. 2009;60(4):706–708.
- Akhavan S, Mohammadi SR, Modarres Gillani M, et al. Efficacy of combination therapy of oral zinc sulfate with imiquimod, podophyllin or cryotherapy in the treatment of vulvar warts. J Obstet Gynaecol Res. 2014;40(10):2110–2113.
- Mahmoudi H, Ghodsi SZ, Tavakolpour S, et al. Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: a double blind, randomized, placebo-controlled trial. Int J Womens Dermatol. 2018;4(2):87–90.
- Sharquie KA, Al-Nuaimy AA. Treatment of viral warts by intralesional injection of zinc sulphate. Ann Saudi Med. 2002;22(1–2):26–28.
- Mohamed EM, Tawfik KM, Mahmoud AM. The clinical effectiveness of intralesional injection of 2% zinc sulfate solution in the treatment of common warts. Scientifica. 2016;2016:1082979.
- Abd El-Magid WM, Nada EEA, Mossa RA. Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study. J Dermatol Treat. 2021;32(3):355–360.
- El Sayed MH, Sayed FS, Afify AA. Intralesional zinc sulfate 2% vs intralesional vitamin D in plantar warts: a clinicodermoscopic study. Dermatol Ther. 2020;33(3):e13308.
- Nofal A, Albalat W, Ismail A, et al. Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study. J Dermatolog Treat. 2020 Jul 9. DOI:10.1080/09546634.2020.1789540.
- Khattar JA, Musharrafieh UM, Tamim H, et al. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol. 2007;46(4):427–430.
- Sharquie KE, Khorsheed AA, Al-Nuaimy AA. Topical zinc sulphate solution for treatment of viral warts. Saudi Medical Journal. 2007;28(9):1418–1421.
- Songsantiphap C, Asawanonda P. Topical 15% zinc oxide ointment significantly reduces the size of common warts after four weeks: a randomized, triple-blinded, placebo-controlled trial. J Clin Aesthet Dermatol. 2019;12(9):26–31.
- Hogendoorn GK, Bruggink SC, de Koning MNC, et al. Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts. Br J Dermatol. 2018;178(1):253–260.
- Korkmaz S, Şirin FB, Erturan I, et al. Coenzyme Q10, zinc and MDA levels in verruca vulgaris. Turk J Med Sci. 2020;50(5):1387–1392.
- Ghanem AH, Esawy AM, Khalifa NA, et al. Evaluation of serum interleukin 17 and zinc levels in recalcitrant viral wart. J Cosmet Dermatol. 2020;19(4):954–959.
- Raza N, Khan DA. Zinc deficiency in patients with persistent viral warts. J Coll Physicians Surg Pak. 2010;20(2):83–86.
- Naseri M, Shahbaz S, Handjani F, et al. Serum zinc levels in patients with multiple warts. J Pak Assoc Dermatol. 2009;19(1):4–8.
- Tamer F, Yukse ME, Karabag Y. Pre-treatment vitamin B12, folate, ferritin, and vitamin D serum levels in patients with warts: a retrospective study. Croat Med J. 2020;61(1):28–32.
- Giacaman A, Granger C, Aladren S, et al. Use of topical nitric-zinc complex solution to treat palmoplantar and periungual warts in a pediatric population. Dermatol Ther. 2019;9(4):755–760.
- Pontini P, Mastorino L, Gaspari V, et al. A multicentre, randomised clinical trial to compare a topical nitrizinc® complex solution versus cryotherapy for the treatment of anogenital warts. Dermatol Ther. 2020;10(5):1063–1073.